Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 14:12:34 GMT 2023
by
admin
on
Sat Dec 16 14:12:34 GMT 2023
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IGG4 |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
8JXN261VVA
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Related Record | Type |
|---|
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
762720
Created by
admin on Sat Dec 16 14:12:35 GMT 2023 , Edited by admin on Sat Dec 16 14:12:35 GMT 2023
|
||
|
FDA ORPHAN DRUG |
836421
Created by
admin on Sat Dec 16 14:12:35 GMT 2023 , Edited by admin on Sat Dec 16 14:12:35 GMT 2023
|
||
|
FDA ORPHAN DRUG |
869622
Created by
admin on Sat Dec 16 14:12:35 GMT 2023 , Edited by admin on Sat Dec 16 14:12:35 GMT 2023
|
||
|
FDA ORPHAN DRUG |
738620
Created by
admin on Sat Dec 16 14:12:35 GMT 2023 , Edited by admin on Sat Dec 16 14:12:35 GMT 2023
|
||
|
FDA ORPHAN DRUG |
730120
Created by
admin on Sat Dec 16 14:12:35 GMT 2023 , Edited by admin on Sat Dec 16 14:12:35 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
8JXN261VVA
Created by
admin on Sat Dec 16 14:12:35 GMT 2023 , Edited by admin on Sat Dec 16 14:12:35 GMT 2023
|
PRIMARY | |||
|
C131334
Created by
admin on Sat Dec 16 14:12:35 GMT 2023 , Edited by admin on Sat Dec 16 14:12:35 GMT 2023
|
PRIMARY | |||
|
10820
Created by
admin on Sat Dec 16 14:12:35 GMT 2023 , Edited by admin on Sat Dec 16 14:12:35 GMT 2023
|
PRIMARY | |||
|
DB15043
Created by
admin on Sat Dec 16 14:12:35 GMT 2023 , Edited by admin on Sat Dec 16 14:12:35 GMT 2023
|
PRIMARY | |||
|
1924598-82-2
Created by
admin on Sat Dec 16 14:12:35 GMT 2023 , Edited by admin on Sat Dec 16 14:12:35 GMT 2023
|
PRIMARY | |||
|
JK-170
Created by
admin on Sat Dec 16 14:12:35 GMT 2023 , Edited by admin on Sat Dec 16 14:12:35 GMT 2023
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 1_152 | 1_208 |
| 1_266 | 1_326 |
| 1_372 | 1_430 |
| 1_139 | 3_219 |
| 1_231 | 2_231 |
| 1_234 | 2_234 |
| 2_22 | 2_96 |
| 2_152 | 2_208 |
| 2_266 | 2_326 |
| 2_372 | 2_430 |
| 2_139 | 4_219 |
| 3_23 | 3_93 |
| 3_139 | 3_199 |
| 4_23 | 4_93 |
| 4_139 | 4_199 |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_302 |
| N | 2_302 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
SUB_CONCEPT->SUBSTANCE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
immunomodulator, antineoplastic
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
|
|||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
|
|||